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I nherited retinal dystrophies (IRD) are a complex group of genetically heterogeneous eye disorders that are caused by Mendelian mutations in over 200 genes (see https://sph.uth. edu/retnet/; provided in the public domain by The University of Texas Health Science Center, Houston, TX, USA). They are initially diagnosed according to the patient's clinical symptoms, their age of onset, and the cell type that is primarily affected by the condition. Knowledge of the underlying genetic defect allows for a more comprehensive description, though the assumption that each genetic disorder may have a unique clinical signature is oversimplified since molecular screening has revealed profound heterogeneity, both clinical and genetic, in inherited retinal diseases. Additionally, we are now starting to appreciate that isolated retinal disease can be associated with variants in genes previously identified as only causing syndromic disease. 1 The neuronal ceroid lipofuscinoses (NCLs) are a group of lysosomal storage disorders resulting from single gene defects in lysosomal hydrolases or lysosomal/endoplasmic reticulum membrane proteins. 2 They are characterized by early onset neurodegeneration associated with accumulation of autofluorescent intracellular inclusions in neurons and extraneuronal tissues. 3 Collectively, they are the most common cause of childhood neurodegenerative disease. Initially classified using clinical and electron microscopic features, the NCLs are now defined primarily by their genetic basis. At least 13 genetic forms are currently recognized (CLN1-8 and CLN10-14); with the exception of CLN4 disease, all are recessively inherited.
Mutations in the major facilitator superfamily (MFS) domaincontaining protein 8 (MFSD8/CLN7, MIM 611124) were found to cause a variant of late-infantile NCL (vLINCL, MIM 610951). [4] [5] [6] [7] [8] Symptoms of vLINCL usually start between the ages of 3 and 6 years, with seizures and developmental regression followed by speech failure, ataxia, visual loss, myoclonus, and ultimately premature death. Recently, recessive mutations in MFSD8 have also been associated with nonsyndromic macular dystrophy in two families. 9 Retinal dysfunction in the absence of syndromic association had not previously been reported. Despite many advances in NCL research, the biological basis for neurodegeneration remains elusive. The present study provides novel mechanistic insights gleaned from detailed phenotypic investigations in 12 patients with MFSD8-associated retinopathy, together with immunolocalization studies in the murine retina. Possible genotypephenotype correlations underlying nonsyndromic and syndromic disease are also discussed.
MATERIALS AND METHODS

Patient Ascertainment and Clinical Evaluation
The study was approved by the appropriate local research ethics committees and the protocol adhered to the tenets of the Declaration of Helsinki. Patients were ascertained from the inherited eye disease clinics at Moorfields Eye Hospital, London (Patients GC19741, GC17967, GC14328, GC18458, GC19832, GC3716, and GC4694), Bradford Royal Infirmary, Bradford (Patient LE1), St. James's University Hospital, Leeds (Patients LE2 and LE3), Casey Eye Institute, Portland (CEI1), and Wilmer Eye Institute, Baltimore (CEI2). A diagnosis of inherited retinal disease was made by an experienced ophthalmologist based on signs and symptoms, including progressive and symmetrical retinal disease.
Detailed clinical investigations included best-corrected visual acuity (VA; Snellen chart), confrontation visual fields, and pattern and full-field electroretinography (PERG, ERG) using techniques that incorporated the International Society of Clinical Electrophysiology of Vision (ISCEV) recommendations. 10, 11 Retinal imaging was performed using color fundus photography (Topcon TRC 50IA retinal camera, Topcon Corp., Tokyo, Japan), spectral-domain optical coherence tomography (Spectralis HRAþOCT, Heidelberg Engineering, Heidelberg, Germany), and 488-nm wavelength fundus autofluorescence (AF) with either a 308 or 558 field (Spectralis HRAþOCT, Heidelberg Engineering).
Molecular Genetic Analysis
Genomic DNA from affected patients was extracted and analyzed either by whole exome (SureSelect All Exon XT Sequencing kit, Agilent Technologies, Santa Clara, CA, USA) or by whole genome sequencing (Illumina TruSeq DNA PCR-free sample preparation kit, Illumina, San Diego, CA, USA, followed by Illumina HiSeq 2500 sequencing as part of the NIHR BioResource-Rare Diseases project) according to the manufacturer's instructions. FastQ files were aligned to the GRCh37 (hg19) reference genome. Potentially pathogenic variants were identified, filtered based on functionality, minor allele frequency (MAF) in public and in-house databases, and on calculated pathogenicity scores. Putative mutations were validated by Sanger sequencing and checked for segregation.
Immunofluorescence and Confocal Microscopy
Sagittal sections from the eyes of 30-day-old mice were incubated with goat polyclonal anti-MFSD8 (S-14; Santa Cruz Biotechnology, Heidelberg, Germany), followed by an Alexa Fluor 568-conjugated donkey anti-goat immunoglobulin (Molecular Probes, Inc., Eugene, OR, USA). Nuclei were counterstained with DAPI (Vector Laboratories, Orton Southgate, UK). As controls, a section was stained with secondary and another was treated with primary antibody that had been preincubated with peptide antigen followed by secondary. For the colocalization experiments, sections were incubated with anti-MFSD8 and either rabbit polyclonal anti-SNAP-25 (ab5666; Abcam, Cambridge, UK) or rabbit polyclonal anti-PSD-95 (ab18258; Abcam) followed by Alexa Fluor 568-conjugated donkey anti-goat immunoglobulin and Alexa Fluor 488conjugated chicken anti-rabbit immunoglobulin (Molecular Probes, Inc.), and counterstained with DAPI. Confocal images were obtained using an Eclipse TE2000-E system microscope (Nikon Corp., Tokyo, Japan) and processed using Nikon EZ-C1 3.50 software.
RESULTS
Molecular Analysis
Nine families were identified by next generation sequencing of genomic DNA from patients with nonsyndromic retinal dystrophy, which included 12 individuals carrying biallelic variants in MFSD8 ( Fig. 1 ). Six of the cases (GC19741, LE1-LE3, CEI1, and CEI2) were compound heterozygotes that carried the variant, c.1006G>C, p.Glu336Gln, paired with one of three other disease-causing alleles. This allele was identified in trans with a null variant (c.103C>T, p.Arg35Ter for GC19741 or c.233G>A, p.Trp78Ter for CEI1 and CEI2) or a missense change (c.1394G>A, p.Arg465Gln for LE1-LE3). The remaining six cases (GC17967, GC14328, GC18458, GC19832, GC3716, and GC4694) were homozygous for the missense variant, c.1361T>C, p.Met454Thr. Three of these individuals (GC17967, GC14328, and GC3716) were the offspring of three separate consanguineous marriages. A common shared founder haplotype of South Asian origin, spanning approximately 1.47 Mb was identified by examining single nucleotide variants in Table S1 ). The variants were found to co-segregate with the disease in all family members from whom DNA was available ( Fig. 1 ).
Clinical Investigations
The clinical features of the 12 cases are summarized in the Table. Central visual loss was the primary complaint in all patients. Patients with isolated maculopathy (GC19741, LE1-LE3, CEI1, and CEI2) developed symptoms at a later age than those with generalized retinopathy (GC17967, GC14328, GC18458, GC19832, GC3716, and GC4694). Patients with a compound heterozygous genotype that included c.1006G>C, p.Glu336Gln had isolated macular disease. In contrast, cases with a homozygous c.1361T>C, p.Met454Thr genotype had more widespread retinopathy, with the majority also reporting night-blindness. No signs or symptoms of neurological disease were apparent. Fundus examination findings ranged from minimal changes (GC19741) to those typical of advanced retinitis pigmentosa (GC3716; Fig. 2A ). Corresponding structural changes were present in all cases when imaged using AF and optical coherence tomography (OCT; Figs. 2B, 2C). Patients with clinically isolated macular disease (CEI1 and GC19741) initially showed only pattern ERG abnormalities, though as the disease progressed the full field ERG could become abnormal, with the photopic single flash ERG (CEI1) showing a disproportionate loss of b-to a-wave leading to a significantly reduced b-to a-wave ratio ( Fig. 3 ). Patients with peripheral retinal signs (GC17967 and GC14328) also had highly abnormal full-field ERGs, in keeping with a severe rodcone dystrophy with marked macular involvement (Fig. 3) . The photopic single flash ERGs (GC17967 and GC14328) again showed reduction in the b to a amplitude ratio. Although there was a lower amplitude b-wave than a-wave in the bright flash dark-adapted ERG, that is likely to be a reflection of a cone isolated retina, with all signals arising from dark-adapted cones, rather than inner retinal dysfunction with the rod system.
CLN7/MFSD8 Localization in the Retina
Confocal immunofluorescence microscopy in the murine retina showed that MFSD8 predominantly localized to the outer plexiform layer (OPL), a region rich in synaptic connections between photoreceptors and second order neurons-bipolar and horizontal cells ( Fig. 4) . Co-localization studies highlighted considerable overlap in the staining pattern for MFSD8 localization and PSD-95, but not SNAP-25, suggesting that MFSD8 is predominantly located at the photoreceptor synaptic terminals rather than bipolar or horizontal cells.
DISCUSSION
Mutations in MFSD8 usually cause vLINCL, a severe, early-onset neurodegeneration characterized by seizures, progressive mental and motor deterioration, myoclonus, visual failure, and ultimately premature death. [4] [5] [6] [7] [8] [14] [15] [16] [17] [18] [19] Atypical presentations also exist, either commencing at a later age associated with mild disease, 7 or a recently described, nonsyndromic form causing only macular disease. 9 The present study describes a fourth consequence of MFSD8 dysfunction: widespread rodcone dystrophy with severe macular involvement. Longitudinal study is needed to determine whether patients with isolated retinal disease eventually develop neurological involvement, , and macular OCT scans (C) from patients GC19741, LE3, CEI1, GC17967, GC14328, GC18458, GC3716, and a normal control subject. GC19741 and CEI1 have disease that is localized to the fovea, with minimal if any signs visible on CFPs. The subtle increase in foveal AF correlates with the outer retinal cavitation on OCT suggesting focal loss of photoreceptors. LE3 manifests a more severe maculopathy. GC17967, GC14328, GC18458, and GC3716 show more extensive disease typical of retinitis pigmentosa with severe macular involvement. Imaging shows pigment migration into the retina and arteriolar attenuation (CFP), and loss of physiological AF, consistent with extensive degeneration of the outer retinal structures (FAF and OCT). GC14328 additionally manifests a ring of increased AF demarcating the central boundary between normal and abnormal retina; in GC3716 the atrophy is so advanced that choroidal vessel AF is visible. though it is reassuring that the three oldest patients reported herein developed no neurological abnormalities despite being in their seventh or eighth decade of life. ERG localizes the consequences of MFSD8 dysfunction more precisely. The scotopic bright flash ERG is a mixed rodcone response, dominated by the rod-system. Most of the negative going a-wave reflects photoreceptor hyperpolarization, with the later positive going b-wave generated in the bipolar cells. The photopic single flash ERG a-wave is generated by cone photoreceptors and Off-(hyperpolarizing) bipolar cells, with the positive b-wave being an effectively synchronized response from On-and Off-bipolar cells. Those patients homozygous for the p.Met454Thr allele demonstrated a reduction in the photopic b to a ratio, a feature not typically associated with primary photoreceptor degeneration. Although a reduced b-to a-wave ratio can occur in the bright flash dark-adapted ERG in cone isolated retinas due to vitamin A deficiency, 20 or RDH5 mutation, 21 when rod loss is so severe that all remaining signals arise in dark-adapted cones, the photopic ERGs do not exhibit such a phenomenon. The reduced photopic b to a ratio in the present series thus indicates dysfunction after phototransduction beyond the photoreceptor outer segment. This contention is further supported in a patient carrying the p.Glu336Gln variant allele, who has isolated macular disease but developed a reduced photopic ERG b-to a-wave ratio over a 6-year period, indicating progressive ''inner retinal'' cone dysfunction. Immunofluorescence of the murine retinal sections demonstrated that the strongest MFSD8 signal arises in the OPL, in the photoreceptor synaptic terminals, in keeping with the electrophysiological data.
TABLE. Clinical Information of Retinal Dystrophy Patients With Biallelic
Thus two independent lines of evidence implicate the OPL in MFSD8-associated retinal disease. The localization of MFSD8 to the photoreceptor presynaptic terminals, together with the presence of a post-phototransduction ERG abnormality in patients with MFSD8 mutations, strongly suggests a synaptic origin for the defect. Synaptic alterations have previously been suggested as initiating events causing NCL in the CLN5knockout sheep 22 and in a mouse model of lysosomal disease due to a defect in cathepsin D function (CLN10). 23 Overall, the data suggest that macular photoreceptors appear to be most sensitive to mutations in MFSD8. Extramacular photoreceptors are the next most vulnerable, with cortical neurons being the most resistant of the affected cell types. There are anatomical and physiological differences between photoreceptor and conventional synapses that could account for this differential vulnerability. Photoreceptor terminals release neurotransmitter continuously, with light turning off vesicle release, whereas cortical neurons are usually switched off and are only triggered by action potentials. To permit these unique properties of photoreceptors, the terminals contain many more synaptic vesicles of which 85% are freely mobile, actively participating in glutamate release, compared to~20% in conventional synapses. [24] [25] [26] [27] Furthermore, photoreceptor termini possess a synaptic ribbon for vesicle docking, necessary for maintaining the higher rates of neurotransmitter release over a sustained period of time. 28 It is also relevant that peripheral cones contain twice as many ribbons as central cones, 29 suggesting that this, or a similar synaptic modification, may underlie the different photoreceptor sensitivities.
To date, MFSD8 has been shown to be a lysosomal membrane protein with an MFS transporter domain that is characteristic of proteins that transport small solutes through chemiosmotic ion gradients. 30 The substrates for MFSD8 are unknown. However, as MFSD8 predominantly localizes to photoreceptor synaptic terminals in the retina, it could be speculated that it may form part of the synaptic vesicles. The consequences of MFSD8 mutation may be synaptic dysfunction resulting in disordered neurotransmitter release and local excitotoxicity. This may lead to downstream secondary consequences that have been described such as the accumulation of aggregate storage material in neuronal cells, 5, 16, 31, 32 impaired autophagy, 33 and cell death, as well as accompanying inflammation that occurs both in the brains of MFSD8-deficient patients 31 and in the MFSD8-knockout dog 34 and mouse models. 33, 35 All previously published MFSD8 mutation combinations associated with disease are listed at http://www.ucl.ac.uk/ncl/ , and the ganglion cell layer (GCL) are shown. Scale bar represents 50 lm. Note that MFSD8 staining predominantly co-localizes with PSD-95, a known marker for presynaptic photoreceptor terminals. 12 SNAP-25 localizes to horizontal cells at the OPL. 13 CLN7patienttable.htm (provided in the public domain by the University College London, UK). The previously described p.Glu336Gln substitution, which gives rise to a ''mild'' variant allele, causes isolated macular dystrophy when paired either with a null variant on the other allele 9 or a missense variant (p.Arg465Gln) as shown here. In direct contrast, the p.Arg465Gln variant, when paired with a null allele, causes vLINCL rather than isolated retinal disease. 14 The other allele of interest, p.Met454Thr, may be considered a ''moderate'' allele since homozygous variants cause a more severe rod-cone dystrophy but not vLINCL. The severe neurological phenotype may only occur when the p.Met454Thr variant is paired with a more severe allele. 17 In addition, an atypical patient with lateonset vLINCL was homozygous for the p.Ala157Pro missense variant, suggesting that allele may be hypomorphic, accounting for the less severe phenotype. 7 All other reported cases with homozygous missense alleles cause vLINCL. A study that overexpressed two vLINCL-causing missense mutations, p.Thr294Lys and p.Pro412Leu, found enhanced proteolytic cleavage of mutant MFSD8 by cysteine proteases, inactivating the protein. It was suggested that some of the missense alleles may represent functional null mutations. 36 Based on the pathogenicity prediction scores of the missense mutations ( Supplementary Table S2 ) and the topology prediction diagram that maps the mutations on the protein sequence ( Fig. 5 ) there appears to be no obvious correlation between the mutations and whether the patient develops vLINCL or nonsyndromic eye disease. The missense changes, p.Glu336Gln and p.Met454Thr, that are associated with nonsyndromic eye disease may disrupt normal protein function either by reducing the transporter function of MFSD8 or by abrogating a yet to be defined specific function that is unique to photoreceptor synapses, but absent from conventional synapses.
To conclude, this study describes patients with isolated retinal disease due to biallelic mutations in MFSD8, a gene more usually associated with vLINCL. The data suggest a genotype/phenotype relationship such that a mild reduction in function results in an isolated later-onset maculopathy; moderate reduction results in an earlier-onset generalized rod-cone dystrophy; and much wider central nervous system pathology if both alleles are functionally null. ERG demonstrates additional dysfunction occurring after phototransduction in the cone system, and immunofluorescence localizes the putative lysosomal transporter MFSD8 to the photoreceptor presynaptic terminals in the retinal OPL. Together these observations support a synaptic defect as the primary basis of pathology for this type of vLINCL and related diseases. Residues that are affected in pathogenic missense mutations giving rise to vLINCL are depicted in red. Note that residues that are important in giving rise to nonsyndromic eye disease are highlighted in green.
